Uploaded April 2025 | Updated November 2026, 3 hours ago
How does bench science get to the bedside? Now, more than ever, understanding how NIH-funded basic science research leads to groundbreaking medical treatments is crucial.
Richard Lifton, an internationally renowned genetics researcher and president of Rockefeller University, will discuss the translation of fundamental discoveries into therapeutic innovations, bridging the gap between laboratory research and clinical applications. Attendees will gain insights into the funding process, the challenges of therapeutic development, and the impact of scientific advancements on public health.
Speaker:
Richard Lifton, MD, PhD, is the president of The Rockefeller University, the former chair of Genetics at Yale University, and the founder of the Yale Center for Genome Analysis. He serves as a director at Roche and its subsidiary, Genentech. Lifton has also served on the Advisory Council to the NIH Director, co-chaired the National Academy of Sciences and Royal Society's International Commission on the Clinical Use of Germline Genome Editing, and co-chaired the White House and NIH's Precision Medicine Planning Group. He was awarded the Breakthrough Prize in Life Sciences and the Association of American Physicians' Kober Medal.
Program
Bob Wachter: Introduction
2:15-54:15 — Richard Lifton, MD, PhD
54:15-59:28 — Q&A
See previous Medical Grand Rounds:
March 25: More Money, Fewer Problems? Examining Guaranteed Income and Housing Stability
• youtu.be/pwwG1y4_gU8
March 11: Air Pollution, Asthma, Allergy, and the Exposome
• youtu.be/RK3T0UAGE0k
February 25: Updates in Large Vessel Vasculitis
• youtu.be/gQX8Ewjr-kI
February 18: The 27th Annual Reza Gandjei Lecture: Focusing on Health Care Equity
• youtu.be/7Z7FM-Apd2s
How does bench science get to the bedside? Now, more than ever, understanding how NIH-funded basic science research leads to groundbreaking medical treatments is crucial.
Richard Lifton, an internationally renowned genetics researcher and president of Rockefeller University, will discuss the translation of fundamental discoveries into therapeutic innovations, bridging the gap between laboratory research and clinical applications. Attendees will gain insights into the funding process, the challenges of therapeutic development, and the impact of scientific advancements on public health.
Speaker:
Richard Lifton, MD, PhD, is the president of The Rockefeller University, the former chair of Genetics at Yale University, and the founder of the Yale Center for Genome Analysis. He serves as a director at Roche and its subsidiary, Genentech. Lifton has also served on the Advisory Council to the NIH Director, co-chaired the National Academy of Sciences and Royal Society's International Commission on the Clinical Use of Germline Genome Editing, and co-chaired the White House and NIH's Precision Medicine Planning Group. He was awarded the Breakthrough Prize in Life Sciences and the Association of American Physicians' Kober Medal.
Program
Bob Wachter: Introduction
2:15-54:15 — Richard Lifton, MD, PhD
54:15-59:28 — Q&A
See previous Medical Grand Rounds:
March 25: More Money, Fewer Problems? Examining Guaranteed Income and Housing Stability
• youtu.be/pwwG1y4_gU8
March 11: Air Pollution, Asthma, Allergy, and the Exposome
• youtu.be/RK3T0UAGE0k
February 25: Updates in Large Vessel Vasculitis
• youtu.be/gQX8Ewjr-kI
February 18: The 27th Annual Reza Gandjei Lecture: Focusing on Health Care Equity
• youtu.be/7Z7FM-Apd2s










